VIVIANI, GIORGIO LUCIANO
 Distribuzione geografica
Continente #
EU - Europa 11.348
AS - Asia 1.276
NA - Nord America 913
SA - Sud America 109
Continente sconosciuto - Info sul continente non disponibili 83
AF - Africa 17
Totale 13.746
Nazione #
IT - Italia 11.134
US - Stati Uniti d'America 853
SG - Singapore 505
CN - Cina 306
VN - Vietnam 192
BD - Bangladesh 142
FR - Francia 92
BR - Brasile 60
HK - Hong Kong 50
FI - Finlandia 39
DE - Germania 28
CA - Canada 24
AR - Argentina 19
CH - Svizzera 17
IN - India 14
IQ - Iraq 14
GB - Regno Unito 13
JP - Giappone 13
CL - Cile 12
ID - Indonesia 10
JM - Giamaica 10
MX - Messico 7
TH - Thailandia 6
GT - Guatemala 5
VE - Venezuela 5
EC - Ecuador 4
IE - Irlanda 4
KE - Kenya 4
KR - Corea 4
PY - Paraguay 4
CO - Colombia 3
ES - Italia 3
HN - Honduras 3
MY - Malesia 3
NL - Olanda 3
PH - Filippine 3
PK - Pakistan 3
RO - Romania 3
CR - Costa Rica 2
JO - Giordania 2
KZ - Kazakistan 2
MA - Marocco 2
NI - Nicaragua 2
PL - Polonia 2
SE - Svezia 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
ZA - Sudafrica 2
AI - Anguilla 1
AT - Austria 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BJ - Benin 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
HT - Haiti 1
LC - Santa Lucia 1
MN - Mongolia 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TR - Turchia 1
TW - Taiwan 1
UA - Ucraina 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.664
Città #
Genova 6.755
Genoa 2.596
Rapallo 985
Vado Ligure 661
San Jose 246
Singapore 246
Ashburn 108
Lauterbourg 83
Ho Chi Minh City 67
Hong Kong 48
Hanoi 43
Beijing 42
New York 39
Helsinki 38
Santa Clara 31
Frankfurt am Main 26
Bordighera 21
Zurich 15
Los Angeles 13
Milan 13
Tokyo 13
Buffalo 12
Rome 12
Council Bluffs 11
Tianjin 10
Atlanta 9
Naples 9
Da Nang 8
Orem 7
Bangkok 6
Chicago 6
Dallas 6
Jakarta 6
Kingston 6
Queens 6
Saint Paul 6
Woodbridge 6
Baghdad 5
Guatemala City 5
Mexico City 5
Toronto 5
Bacoli 4
Biên Hòa 4
Bologna 4
Boston 4
Brooklyn 4
City of London 4
Dayton 4
Dublin 4
Haiphong 4
Hải Dương 4
Nha Trang 4
Phoenix 4
Princeton 4
Santiago 4
Seattle 4
Asunción 3
Baltimore 3
Cardiff 3
Chennai 3
Chula Vista 3
Cincinnati 3
Columbus 3
Des Moines 3
Dover 3
Florence 3
Guayaquil 3
Las Vegas 3
Miami 3
Nairobi 3
Ninh Bình 3
Orlando 3
San Carlo Canavese 3
San Francisco 3
Washington 3
Akron 2
Amman 2
Amsterdam 2
Antioch 2
Bari 2
Belo Horizonte 2
Belém 2
Bengaluru 2
Braham 2
Brasília 2
Brescia 2
Cagliari 2
Casablanca 2
Catania 2
Charlotte 2
Columbia 2
Dakar 2
Detroit 2
Downey 2
East Orange 2
Erbil 2
Garland 2
Guangzhou 2
Guarulhos 2
Gujranwala 2
Totale 12.402
Nome #
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome. 280
Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus 232
An emerging role of glucagon-like Peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes. 231
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 228
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. 219
N-Acetyl-L-Cysteine Prevents Effects Of Pentosidine on the Pancreatic Beta-Cell Line HIT-T15 214
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 213
Glucagon-Like Peptide-1 Secreting Cell Function as well as Production of Inflammatory Reactive Oxygen Species Is Differently Regulated by Glycated Serum and High Levels of Glucose. 209
CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. 206
Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15 198
Insulin primes human neutrophils for CCL3-induced migration: crucial role for JNK 1/2. 196
Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis. 189
Effects of valsartan therapy on protein glycoxidation. 189
Statins in the treatment of acute ischemic stroke. 188
Water distribution in insulin-dependent diabetes mellitus in various states of metabolic control. 182
Advanced Glycation End-products affect subcellular localization of the transcription factors regulating insulin gene transcription. 181
Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus. 180
Influence of cell age and ketoaminic linkage on rapid glycosylation of hemoglobin in human red cells in vitro. 178
New evidence for nicotinic acid treatment to reduce atherosclerosis. 176
A method for erythrocyte filtration. 175
Glucagon-Like Peptide-1 Triggers Protective Pathways in Pancreatic Beta-Cells Exposed to Glycated Serum. 174
Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System 174
An instrument for real-time spectral estimation of heart rate variability signals. 172
Impairment of central motor conduction in diabetic patients. 172
Advanced glycation endproducts and diabetes. Beyond vascular complications. 169
Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium. 168
Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes. 165
I.V. glucose tolerance test: correlation between FFA, glucose and IRI in normal, obese and diabetic subjects. 164
Autonomous artificial intelligence versus teleophthalmology for diabetic retinopathy 163
Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T15. 158
Analysis of non-fibroblastic interstitial cells of human pancreas. 157
Role of cytokines and chemokines in non-alcoholic fatty liver disease. 156
Bcl-2 family and caspase-3 gene expression in fas-mediated apoptosis of isolated rat islets. 153
Exploration of the early insulin response by two small successive loads of I.V. glucose in normal and obese subjects. 152
Retinal Pigment Epithelial Cells Express a Functional Receptor for Glucagon-Like Peptide-1 (GLP-1). 152
Update on the Protective Molecular Pathways Improving Pancreatic Beta-Cell Dysfunction. 152
[Psychological aspects in the therapy of diabetes]. 151
Response to anti-VEGF-A treatment of endothelial cells in vitro 150
Response to anti-VEGF-A treatment of retinal pigment epithelial cells in vitro. 149
Effetti degli AGEs sulla Linea Cellulare HIT-T15 Insulino-secernente 148
Differente effetto ossidativo indotto da pentosidina e siero glicato ed efficacia del trattamento antiossidante con N-acetilcisteina su linee HIT-T15 e ARPE-19 145
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. 144
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. 144
Caveolin-1 is essential for glimepiride-induced insulin secretion in the pancreatic betaTC-6 cell line 142
P87 Effect of exenatide, sitagliptin and vildagliptin on IGF-I in diabetic patients 142
RANKL/OPG pathway is a promising target to reduce atherosclerosis plaque calcification. 141
Lercanidipine in type II diabetic patients with mild to moderate arterial hypertension. 139
[NEFA behavior and its correlations with IRI during IVGTT in normal, obese and diabetic subjects]. 134
GLP-1 PREVENTS AGEs-INDUCED PANCREATIC BETA CELL DYSFUNCTION. 133
Reduced glucose effectiveness as a feature of glucose intolerance evidence in elderly type-2 diabetic subjects. 132
Effects on glycation of Valsartan therapy in vivo. 130
Azathioprine decreases insulin secretion in human islets. 127
Effects of advanced glycation end-products on GLP-1 secreting cells 125
Effect of nicotinic acid associated with retinol and tocopherols on plasma lipids in hyperlipoproteinaemic patients. 122
Repaglinide-metformin combination in the treatment of type 2 diabetes: Comparison between three different combination regimens. 122
Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials. 121
Application of the hydraulic shaking system to isolation of human pancreatic islets 119
RETINAL PIGMENT EPITHELIAL CELLS EXPRESS A FUNCTIONAL RECEPTOR FOR GLUCAGON-LIKE PEPTIDE-1. 118
[Pathology of the periodontium in diabetes mellitus: possible pathogenetic correlations and therapeutic indications]. 118
Oral tolerance and allograft: can multiple oral administrations of low doses of highly purified islets induce periferal tolerance in pancreatic islets allograft? 117
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials 117
Isolation of pig pancreatic islets by a new method with hydraulic shaking 116
null 116
Pioglitazone attenuates the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T15. 113
Type 2 diabetes in elderly: assessment and treatment. A review and personal observational data (part II). 112
Prednisolone protects pancreatic B-cells agaist cyclosporine and azathioprine effects. 111
Oxidative stress, homocysteine and platelet function in NIDDM patients 110
In beta-TC cells nicotinamide prevents IL-1 beta-induced apoptosis blocks caspase-3 activation and up-regulates Bcl-2 109
Indipendence of morphological and functional aspects of pseudoislets from gel collagen matrix. cell 108
Rat serum improves rat pseudoislet formation and insulin gene expression. 107
Correlations between gamma-glutamyl-transpeptidase, triglycerides and cholesterol in normal, obese and diabetic subjects. 107
Receptor activator of NF-kappa B ligand (RANKL) increases neutrophilic degranulation and potentially associated cardiovascular risk. 106
Insulin response and NEFA behavior in volunteers with a flat response to oral glucose tolerance test. 106
[Non-insulin-dependent diabetes mellitus in the young]. 105
[Left ventricular diastolic function in type I diabetes. A longitudinal echocardiographic study]. 105
I problemi dell'anziano con un piede diabetico 104
Glycated FBS affects the viability of an insulin-secreting cell line in vitro. 102
The cannabinoid receptor type 2 is down-regulated in downstream portions of human carotid plaques. 101
L'approccio clinico-terapeutico al paziente diabetico anziano nelle diverse realtà assistenziali: revisione della letteratura ed esperienza personale (Seconda parte) 101
Long-term follow-up of human islet autotransplantation. 97
Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization 97
Effects of pindolol in insulin secretion. II. OGTT changes after pindolol therapy. 96
Regulation of VEGF by pentosi dine and glycated serum 94
Prevention of rejection and fibrosis: considerations in 25 patients. 94
GLUCOSE INTERORGAN EXCHANGE IN CHRONIC RENAL FAILURE 93
Double test of insulin sensitivity in normal and obese subjects. 93
[Insulin secretion and hepatic extraction in juvenile non-insulin-dependent diabetes]. 93
Glycated serum decrease insulin secretion of the pancreatic beta cell line HIT-T15 91
Cardiac function in the insulin-dependent juvenile diabetic: evaluation with echocardiography, polygraphy and dynamic electrocardiography. 90
Serum osteopontin predicts glycaemic profile improvement in metabolic syndrome: A pilot study 89
Correlations between NEFA and ketone bodies in normal and diabetic subjects. 88
Effects of pindolol on insulin secretion. I. Insulin response to small intravenous loads of glucose and to pindolol infusion. 88
MiR-126 Mimic Counteracts the Increased Secretion of VEGF-A Induced by High Glucose in ARPE-19 Cells 86
Differential effects of insulin on glycemia, NEFA and ketone bodies in diabetic subjects. 86
Glycated Serum Decreases Insulin Content and Modifies the Expression of Proteins Involved in Insulin Granule Exocytosis. 86
Special aspects of the curve of the oral glucose tolerance test. 83
Islet autotransplantation in humans--a model for allotransplantation. 82
Examination of the early phase of insulin secretion with 3 successive small overloads of glucose (5 g) in normal and obese subjects. 80
Effects of normoglycemia after a low carbohydrate diet in NIDDM. Insulin secretion and effectiveness. 77
Pathophysiological role of inflammatory molecules in paediatric ischaemic brain injury. 29
Totale 13.746
Categoria #
all - tutte 40.709
article - articoli 37.150
book - libri 0
conference - conferenze 3.559
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.174 37 78 40 180 56 90 83 265 34 117 35 159
2022/20231.195 115 73 13 113 227 206 0 91 219 9 107 22
2023/2024593 23 89 7 68 56 120 30 29 35 17 41 78
2024/20251.682 49 120 48 93 232 177 134 295 55 85 172 222
2025/20263.146 376 63 184 251 416 270 567 134 196 291 189 209
2026/2027300 300 0 0 0 0 0 0 0 0 0 0 0
Totale 13.746